Navigation Links
New Drug Promises Prolonged Survival in Prostate Cancer Patients

A new anti-cancer drug called pertuzumab, shows promise in slowing progression and prolonging survival time in men with prostate cancer.//

A new class of targeted anti-cancer drugs that blocks the human epidermal growth factor (HER) receptor family shows promise in prolonging the lives of patients with recurrent prostate cancer, a new Cedars-Sinai study shows. The drug, a molecular targeted compound called pertuzumab, works by binding to and inhibiting the function of HER2 receptors, interrupting a key pathway that leads to cancer growth.

The study, published in the February 20 issue of the Journal of Clinical Oncology, involved 41 patients with treatment-resistant prostate cancer who had experienced progression of their disease after prior chemotherapy. Patients received the drug every three weeks until disease progression. MRI and CAT scans were used to evaluate the tumors during the period of drug therapy. While no shrinkage of tumors was reported, retrospective analysis showed that survival rate was prolonged to 16.4 months with the drug as compared to a median average of 10.7 months in a historical control group with similar baseline prognostic features.

“Advanced prostate cancer is difficult to treat – and the drug therapies currently available to these patients have not been very effective, especially in patients whose disease has progressed after chemotherapy treatment,” said David B. Agus, M.D., principal investigator of the study and research director of Cedars-Sinai’s Louis Warschaw Prostate Cancer Center at the Samuel Oschin Comprehensive Cancer Institute. “Pertuzumab may offer a new treatment approach for these patients when it is evaluated as a tool to slow – not stop or shrink -- tumor growth.”

“The theory is that by significantly slowing progression of the cancer, patients will experience a good quality of life for a longer period of time,” said Agus. “Ultimately, we hope drugs like pertuzumab will help
'"/>




Page: 1 2 3

Related medicine news :

1. Marijuana-Derived Drug Promises Hope In Treating Bladder Infection
2. LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems
3. Diarrhea Vaccine Trials Promises Prevention of Rotavirus Infection
4. Maternal Vitamin D Supplementation Promises Healthy Bones In Child
5. Raw Vegan Diet Promises Lightweight, Healthy Bones
6. Stem Cell Transplantation Promises Cure for Type 2 Diabetes
7. New Drug Promises Hope In Multiple Drug Resistant And Latent TB Treatment
8. Health Minister Promises Strict Quality Control On Herbal Medicines
9. Anti-Cancer Treatment Promises Hope in Bird Flu Treatment
10. Nanotechnology Promises Huge Medical Benefits
11. Health Minister Promises New Benchmark for Wait Times
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Drug Promises Prolonged Survival Prostate Cancer Patients

(Date:7/9/2014)... almost all types of cancer sends the protein factories ... a tumour,s uncontrolled growth, new research suggests. , Scientists ... molecular trigger responsible for ratcheting up activity of the ... the building blocks cancer cells need to keep growing. ... SREBP, controls the flow of messages to the endoplasmic ...
(Date:7/9/2014)... type of lung cancer, researchers have uncovered mutations in ... tumors. The new knowledge may expand treatments for patients ... are available or are in clinical trials. , Reporting ... Cancer Genome Atlas (TCGA), including researchers at Washington University ... and other institutions, studied tumors from 230 patients with ...
(Date:7/9/2014)... a relatively optimistic picture of women,s chances of surviving ... the chest wall or skin, but not beyond. ... size and whether they have involved lymph nodes, are ... advanced" tumors, suggesting that they are a relatively serious ... breast cancers of this and other types account for ...
(Date:7/9/2014)... BostonPractices used in policing injection drug users in ... mortality. , A study, conducted by researchers ... Health, in collaboration with St. Petersburg Pavlov State ... had on the health outcomes of a cohort ... use. , Those who were arrested by police ...
(Date:7/9/2014)... feelings are personal and subjective, the human brain ... represents emotions across different senses, situations and even ... neuroscientist Adam Anderson. , "We discovered that fine-grained ... an area of the brain associated with emotional ... an individual,s subjective feeling," says Anderson, associate professor ...
Breaking Medicine News(10 mins):Health News:Signal may send cancer's cellular factories into overdrive 2Health News:Lung cancer study hints at new treatments 2Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 2Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 3Health News:BU researchers relate arrests with HIV risk environment 2Health News:Study cracks how the brain processes emotions 2
... (HealthDay News) -- Men with high amounts of the controversial ... have impaired semen quality, a new study of factory workers ... National Institute of Occupational Safety and Health, found high urine ... drop in sperm concentration, overall sperm count, sperm vitality and ...
... Wisconsin are conducting the KAST clinical trial at ... of a new vertebral augmentation treatment (Kiva) for ... Sean Tutton, M.D, associate professor ... is principal interventional radiology investigator for this multi-institutional, ...
... Reporter , THURSDAY, Oct. 28 (HealthDay News) -- Better treatments are ... AIDS-causing virus takes a toll that will challenge the health care ... HIV-positive men and women ages 50 and older living in New ... much higher rate than others their age without HIV. And ...
... in everything from laws about using your cell phone while ... pass on fourth down come to Austin on November 7, ... people who use math for a living but also problem ... of the Institute for Operations Research and the Management Sciences ...
... to different prescription drug plans because Part D reimbursements ... the actual costs incurred, according to a study released ... describes how a system designed to encourage competition and ... led companies to raise their premiums in an effort ...
... HealthDay Reporter , THURSDAY, Oct. 28 (HealthDay News) -- ... might help protect women from breast cancer, a new, ... "We found no overall association between green tea intake ... who have habitually drunk green tea," said lead researcher ...
Cached Medicine News:Health News:Plastics Chemical BPA Tied to Poor Sperm Quality 2Health News:Plastics Chemical BPA Tied to Poor Sperm Quality 3Health News:National research study to assess new treatment for painful vertebral fractures 2Health News:More Older Americans Living With HIV 2Health News:More Older Americans Living With HIV 3Health News:4,000 numbers crunchers count on Austin 2Health News:Study identifies flaws in Medicare prescription drug program 2Health News:Study Finds Green Tea Offers No Protection From Breast Cancer 2
(Date:1/15/2014)...  In an unprecedented effort to curb the spread of "superbugs" such ... vehicles, an advanced and portable UV germicidal lamp manufactured by MRSA-UV ... In order to prevent EMS paramedics and transport ... West Palm Beach Fire Rescue is the first in ...
(Date:1/15/2014)... 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ECTE ... CGM System as a non-invasive, wireless continuous glucose monitoring ... Executive Chairman and Interim CEO of Echo Therapeutics, will ... Equity Conference. Mr. Doman will make ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining ...
Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
... , NEW YORK, Nov. 17 ... research report is available in its catalogue. ... Biomaterials 2009 (15 Countries) , ... 2008, the combined European biomaterial market was ...
... , BEIJING, ... developer and provider of vaccines in China, announced today that ... Administration,for Panflu.1, the Company,s H1N1 vaccine. The population has been ... for PANFLU.1 was extended to,one year from six months. , ...
Cached Medicine Technology:Reportlinker Adds European Markets for Orthopedic Biomaterials 2009 (15 Countries) 2Sinovac's PANFLU.1 (H1N1) Regulatory Approval Expanded to Include Geriatric Population 2
Sabre 180, 230V, 50Hz is a powerful niche generator....
High performance capabilities in a multipurpose generator, blended cut modes, simultaneous independent coagulation, low voltage coagulation, valleylab REM safety substantially reduces the risk of pat...
Lorgnette pinhole occluder...
Black multi-pinhole occluder...
Medicine Products: